Expression analysis, targeted mutagenesis and misexpression studies in mice and chickens have indicated that the 5′ HoxD genes and their paralogs in the HoxA cluster are critical for limb development [8]. To date, mutations that cause

human limb malformation have been found in two such genes: HOXD13 in brachydactyly, type D (OMIM 113200), brachydactyly, type E (OMIM 113300), brachydactyly–syndactyly syndrome (OMIM 610713), syndactyly, type V (OMIM 186300), synpolydactyly with foot anomalies (OMIM 186000), synpolydactyly, type II (OMIM 186000) and VACTERL association (OMIM 192350) and HOXA13 in hand–foot–genital syndrome (OMIM GSK-3 inhibitor 140000) and Guttmacher syndrome (OMIM 176305) [9]. Syndactyly is a condition in which two or more digits

are fused together. It is one of the most frequent congenital limb abnormalities and occurs as an isolated anomaly or a part of a malformation syndrome [10]. Syndactyly exhibits high inter- and intra-familial clinical variability; even within a subject, the phenotype can be unilateral or bilateral and symmetrical or asymmetrical [11]. At least nine non-syndromic syndactylies with additional sub-types have been characterized, and most of the syndactyly types are inherited as autosomal dominant, but two autosomal recessive and an X-linked recessive entities have also been described [11]. Synpolydactyly (SPD), or syndactyly type II, is defined as a connection between the middle and ring fingers and 4/5 toes, and it is variably associated with postaxial polydactyly GSI-IX in vitro in the same digits. Minor local anomalies and various metacarpal or metatarsal abnormalities may be present [12]. Numerous studies have demonstrated that this type of syndactyly is caused by mutations in HOXD13. To further explore the role of HOXD13 in human limb development, we investigated a two-generation Chinese family with limb malformations. We report a novel missense mutation within HOXD13 that

substitutes a glycine at position 220 for an alanine (G220A). Phenotypic study showed that it was a variant oxyclozanide form of a milder SPD phenotype among affected family members. We also characterized the effects of this mutation and found that the c.659G>C (p.Gly220Ala) mutation may reduce the transcriptional activity of HOXD13 and thereby affect human limb development. Venous blood samples were collected from unaffected (n = 8) and affected individuals (n = 5) in this family (n = 13). An additional unrelated 100 healthy individuals were used as controls. After informed consent and approval from the local ethics committee, genomic DNA was isolated from venous blood samples using standard methods. Digital images of both hands and feet of the proband and his father were taken using Canon EOS 7D (Canon, Tokyo, Japan). Two exons and splice sites of HOXD13 were amplified by polymerase chain reaction (PCR) using three pairs of previously described gene-specific primers [13] (Table 1).